Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-02 @ 12:26 PM
Study NCT ID:
NCT00911859
Status:
COMPLETED
Last Update Posted:
2014-11-18
First Post:
2009-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-29
First Submit QC Date:
None
Study First Post Date:
2009-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-11
Results First Submit QC Date:
None
Results First Post Date:
2014-11-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-03-31
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-11-17
Last Update Post Date:
2014-11-18
Last Update Post Date Type:
ESTIMATED